{
  "docId": "019de072-4935-7342-8528-4e6eca3fe5c7",
  "docSlug": "31ea92baba83669e6443d115d329d67b",
  "documentTitle": "AstraZeneca | Investor Presentation Deck | 53 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 51,
  "pageCount": 53,
  "prevPage": 50,
  "nextPage": 52,
  "slideType": "other",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 3,
  "notes": "The slide uses a matrix layout to map drug indications against patient populations and treatment lines.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-4935-7342-8528-4e6eca3fe5c7/51",
  "deckHref": "/decks/019de072-4935-7342-8528-4e6eca3fe5c7",
  "deckJsonHref": "/decks/019de072-4935-7342-8528-4e6eca3fe5c7.json",
  "deckAnchorHref": "/decks/019de072-4935-7342-8528-4e6eca3fe5c7#slide-51",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.95,
        "x": 0.03,
        "y": 0.22
      },
      "kind": "diagram",
      "text": null,
      "attrs": null,
      "subkind": "matrix-nxn",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bff24d4e-fcaf-4610-bc4d-85863923a79e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.25,
        "x": 0.73,
        "y": 0.87
      },
      "kind": "source-note",
      "text": "1. HER2-low prevalence is anticipated to be c.35-40% in TNBC 2. Antibody drug conjugates (Enhertu and datopotamab deruxtecan) 3. Immunotherapy 4. Chemotherapy.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "26f4d344-aa0e-45f3-85fa-b362fe5ea15d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.8,
        "x": 0.03,
        "y": 0.12
      },
      "kind": "title",
      "text": "Potential to cover most patients across settings and lines of treatment",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "457431c9-16a7-4155-b8ae-dfe9698328b5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.75,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "Breast cancer: well-positioned with at least six medicines",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "61d6afee-541d-4406-97ae-4d8a4df52fd2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "matrix-nxn",
      "slug": null,
      "matchId": "77a7724c-dc33-4473-a6e7-de7a259f5a86",
      "evidence": "The slide maps drug indications against patient segments and treatment lines in a grid format.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}